XV-type HRV-HRV Deprehensio - identifies praesentia et operatio HR-HPV

Ceruicis cancer, ducens causa mortalitatis mulieribus worldwide, maxime per HPV infectio. Et oncogenic potentiale de HR-HPV infectio pendent auctus expressions E6 et E7 genes. Et E6 et E7 proteins ligare ad tumorem supprimor proteins p53 et PRB respectively, et coegi ceruicis cellula proviferation et transmutatio.

Tamen, HPV DNA testing confirmat viral praesentia, non discernit inter latentem et active transcribing infectiones. In Contra, et Deprehensio HPV E6 / E7 MRNA transcripts serves ut magis specifica Biomarker de activo virales ONCENOR expressio, et sic est magis accurate predictor de underlying ceruicis intraepithelia Neoplasia (cin) vel Psidium Carcinoma.

HPV E6 / E7 MRNATesting offert significant commoda in ceruicis cancer ne:

  • Accurate periculo aestimationem: agnoscit activae, summus periculo HPV Infectiones, providente magis praecise periculo aestimationem quam HPV DNA temptationis.
  • Efficens Triage: Guides Clinicians in identifying aegris qui opus ulterius inquisitio, reducendo necesse elit.
  • Potential protegendo tool: ut serve sicut standalone protegendo tool in futurum, praesertim summus periculo populationibus.
  • XV genera High-Periculum Humanum Papillomavirus E6 / E7 Gene MRNA Deprehenter Kit (Fluorescence PCR) a #mmt, HRV Texts et / vel Patientes estote administratione.

Product Features:

  • Plena Coverage: XV HRV HPV Fervidum Related cum ceruicis cancer operuit;
  • Optimum sensibilitatem: D copies / ml;
  • PRAEFECTIO: Nemo crucis actio cum Cytomegalovirus, HV II et Humanum Genomic DNA;
  • Sumptus-effective: Testing peltas magis propinqua connectuntur cum possibile morbus, ut minimize necesse examinations cum susicivus costs;
  • Optimum accurate: IC ad totum processus;
  • Lata compatibility: cum amet PCR systems;

Post tempus: Jul, 25-2024